Response assessment criteria for brain metastases: Proposal from the RANO group

The Lancet Oncology

Volumn 16, Issue 6, 2015, Pages e270-e278

  Lin, Nancy U ^a   Lee, Eudocia Q ^a   Aoyama, Hidefumi ^b   Barani, Igor J ^c   Barboriak, Daniel P ^d   Baumert, Brigitta G ^e   Bendszus, Martin ^f   Brown, Paul D ^g   Camidge, D Ross ^h   Chang, Susan M ⁱ   Dancey, Janet ^j   de Vries, Elisabeth G E ^k   Gaspar, Laurie E ^l   Harris, Gordon J ^m   Hodi, F Stephen ^a   Kalkanis, Steven N ⁿ   Linskey, Mark E ^c,o   Macdonald, David R ^p   Margolin, Kim ^q   Mehta, Minesh P ^r   Schiff, David ^s   Soffietti, Riccardo ^t   Suh, John H ^u   van den Bent, Martin J ^v   Vogelbaum, Michael A ^u   Wen, Patrick Y ^a   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF BONN   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j QUEEN S UNIVERSITY   (Canada)

^k UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^l UNIVERSITY OF COLORADO   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ HENRY FORD HEALTH SYSTEM   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF WESTERN ONTARIO   (Canada)

^q STANFORD UNIVERSITY   (United States)

^r UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF VIRGINIA   (United States)

^t UNIVERSITY OF TURIN   (Italy)

^u LERNER RESEARCH INSTITUTE   (United States)

^v ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GADOLINIUM;

ASSESSMENT OF HUMANS; BRAIN METASTASIS; CANCER DIAGNOSIS; CANCER GROWTH; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DATA ANALYSIS; DIAGNOSTIC IMAGING; GENERAL CONDITION DETERIORATION; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RESPONSE ASSESSMENT IN NEUROONCOLOGY BRAIN METASTASIS GROUP; REVIEW; SYNDROME DELINEATION; VOLUMETRY; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL (TOPIC); GLIOMA; PATHOLOGY; SECONDARY;

BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; CLINICAL TRIALS AS TOPIC; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84930246930     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)70057-4     Document Type: Review

References (22)

1. Davis FG, Dolecek TA, McCarthy BJ, Villano JL Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data. Neuro Oncol 2012, 14:1171-1177.
2. Cancer Facts & Figures 2007, American Cancer Society, American Cancer Society, Atlanta, GA.
3. Lin NU, Lee EQ, Aoyama H, et al. Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group. Lancet Oncol 2013, 14:e396-e406.
4. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45:228-247.
5. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216.
6. Miller AB, Hoogstraten B, Staquet M, Winkler A Reporting results of cancer treatment. Cancer 1981, 47:207-214.
7. Macdonald DR, Cascino TL, Schold SC, Cairncross JG Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990, 8:1277-1280.
8. Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010, 28:1963-1972.
9. Lin NU, Wefel JS, Lee EQ, et al. Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol 2013, 14:e407-e416.
10. Schellinger PD, Meinck HM, Thron A Diagnostic accuracy of MRI compared to CCT in patients with brain metastases. J Neurooncol 1999, 44:275-281.
11. Sze G, Milano E, Johnson C, Heier L Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 1990, 11:785-791.
12. Patel TR, McHugh BJ, Bi WL, Minja FJ, Knisely JP, Chiang VL A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases. AJNR Am J Neuroradiol 2011, 32:1885-1892.
13. Shah R, Vattoth S, Jacob R, et al. Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. Radiographic 2012, 32:1343-1359.
14. Wolchok JD, Hoos A, O'Day S, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res 2009, 15:7412-7420.
15. Bauknecht HC, Romano VC, Rogalla P, et al. Intra- and interobserver variability of linear and volumetric measurements of brain metastases using contrast-enhanced magnetic resonance imaging. Invest Radiol 2010, 45:49-56.
16. Harris GJ, Plotkin SR, Maccollin M, et al. Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II. Neurosurgery 2008, 62:1314-1320.
17. Sze G, Mehta M, Schultz C, et al. Radiologic response evaluation of brain metastases: uni-dimensional (1D), W.H.O. RECIST vs bi-dimensional (2D) or 3-dimensional (3D) criteria. Proc Am Soc Clin Oncol 2001, 20(suppl). abstr 234.
18. van der Weide H, de Kunder S, Houben R, Bosmans G, Lambin P, Baumert BG Influence of metastatic volume on local control and survival assessed by 3D volumetric measurements after radiosurgery in patients with brain metastases and planned observation. Strahlenther Onkol 2011, 187:523-524. (abstr).
19. Yang DY, Sheehan J, Liu YS, et al. Analysis of factors associated with volumetric data errors in gamma knife radiosurgery. Stereotact Funct Neurosurg 2009, 87:1-7.
20. Pan HC, Cheng FC, Sun MH, Chen CC, Sheehan J Prediction of volumetric data errors in patients treated with gamma knife radiosurgery. Stereotact Funct Neurosurg 2007, 85:184-191.
21. Lin NU, Dieras V, Paul D, et al. Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res 2009, 15:1452-1459.
22. Hudis CA, Barlow WE, Costantino JP, et al. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol 2007, 25:2127-2132.